DATISCA cannabina D 3 tablets, 80 pcs

Instructions for use for DATISCA cannabina D 3 tablets, 80 pcs

Directions for use of the article Datisca Cannabina D 3 Tablets. Datisca Cannabina D 3 is a registered homeopathic medicinal product for which the therapeutic indication is not stated. It contains the medicinally active ingredient Datisca Cannabina D 3 Trit. 250 mg, and lactose and wheat starch as other ingredients. The medicinal product is manufactured by the Deutsche Homöopathie-Union. If self-administered, a doctor should be consulted in the event of persistent, unclear or new complaints. There are currently no known restrictions on the use of Datisca Cannabina D 3. During pregnancy and breast-feeding, the medicinal product should only be used after consulting a doctor. The application does not require any special precautions. No interactions with other medicines are known so far. Homeopathic medicines should not be taken over a long period of time unless advised by a doctor. If larger quantities are taken, gastrointestinal complaints may occur in persons with lactose intolerance. No side effects have been reported so far. The expiry date of the medicinal product is stated on the packaging, so it should not be used after this date. It should be kept out of the reach of children. The tablets are available in pack sizes of 80 and 200 and require a prescription. Please read the package leaflet for more information and contact your doctor or pharmacist if you have any questions. Note: The information provided is from the package insert and the summary does not contain repeated information. No tables, bold or colored tags are used.